The recent revelation that the gut microbiome, home to approximately 100 trillion
microorganisms, is implicated in the development of both health and disease has spurred an …

Simple Summary Glioblastoma (GBM) is the most aggressive brain tumour. Patients with
GBM have a dismal survival and there is a distinct lack of curative treatments. We are …

The occurrence and progression of colorectal cancer (CRC) are closely related to intestinal
microecological disorders. Butyrate, the representative of short chain fatty acids, possess …

Glioma is a common primary aggressive tumor with limited clinical treatment. Recently,
growing research suggests that gut microbiota is involved in tumor progression, and several …

Gut microbiota is associated with the growth of various tumors, including malignant gliomas,
through the brain-gut axis. Moreover, the gut microbiota in patients with malignant tumors …

Glioma is the most common intracranial tumor with poor treatment outcomes and has high
morbidity and mortality. Various studies on genomic analyses of glioma found a variety of …

Glioma is the most common malignant tumor of the central nervous system (CNS), with high
degree of malignancy and poor prognosis. The gut microbiome (GM) is composed of …

Background Temozolomide (TMZ) is the preferred chemotherapy strategy for glioma
therapy. As a second-generation alkylating agent, TMZ provides superior oral bio …

Introduction Post-stroke depression (PSD) is the most common emotional problem following
a stroke, which requires early diagnosis to improve the prognosis. Gut microbiota plays …

Gastrointestinal dysmotility is a common cause of functional dyspepsia. As two kinds of
polysaccharides derived from brown algae, fucoidan and laminarin possess many …